119 related articles for article (PubMed ID: 28989041)
1. Deciphering molecular mechanisms of arginine deiminase-based therapy - Comparative response analysis in paired human primary and recurrent glioblastomas.
Maletzki C; Rosche Y; Riess C; Scholz A; William D; Classen CF; Kreikemeyer B; Linnebacher M; Fiedler T
Chem Biol Interact; 2017 Dec; 278():179-188. PubMed ID: 28989041
[TBL] [Abstract][Full Text] [Related]
2. Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo.
Fiedler T; Strauss M; Hering S; Redanz U; William D; Rosche Y; Classen CF; Kreikemeyer B; Linnebacher M; Maletzki C
Cancer Biol Ther; 2015; 16(7):1047-55. PubMed ID: 25774632
[TBL] [Abstract][Full Text] [Related]
3. Arginine-Depleting Enzymes - An Increasingly Recognized Treatment Strategy for Therapy-Refractory Malignancies.
Riess C; Shokraie F; Classen CF; Kreikemeyer B; Fiedler T; Junghanss C; Maletzki C
Cell Physiol Biochem; 2018; 51(2):854-870. PubMed ID: 30466103
[TBL] [Abstract][Full Text] [Related]
4. PEGylation increases antitumoral activity of arginine deiminase of Streptococcus pyogenes.
Schwarz R; Zitzow E; Fiebig A; Hering S; Humboldt Y; Schoenwaelder N; Kämpfer N; Volkmar K; Hinz B; Kreikemeyer B; Maletzki C; Fiedler T
Appl Microbiol Biotechnol; 2022 Jan; 106(1):261-271. PubMed ID: 34910240
[TBL] [Abstract][Full Text] [Related]
5. The addition of arginine deiminase potentiates Mithramycin A-induced cell death in patient-derived glioblastoma cells via ATF4 and cytochrome C.
Linke C; Freitag T; Riess C; Scheffler JV; Del Moral K; Schoenwaelder N; Fiedler T; Fiebig A; Kaps P; Dubinski D; Schneider B; Bergmann W; Classen CF; Maletzki C
Cancer Cell Int; 2023 Feb; 23(1):38. PubMed ID: 36843002
[TBL] [Abstract][Full Text] [Related]
6. Citrulline protects Streptococcus pyogenes from acid stress using the arginine deiminase pathway and the F1Fo-ATPase.
Cusumano ZT; Caparon MG
J Bacteriol; 2015 Apr; 197(7):1288-96. PubMed ID: 25645553
[TBL] [Abstract][Full Text] [Related]
7. The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells.
Matteoni S; Abbruzzese C; Matarrese P; De Luca G; Mileo AM; Miccadei S; Schenone S; Musumeci F; Haas TL; Sette G; Carapella CM; Amato R; Perrotti N; Signore M; Paggi MG
J Exp Clin Cancer Res; 2019 May; 38(1):202. PubMed ID: 31101126
[TBL] [Abstract][Full Text] [Related]
8. Engineering an arginine catabolizing bioconjugate: Biochemical and pharmacological characterization of PEGylated derivatives of arginine deiminase from Mycoplasma arthritidis.
Wang M; Basu A; Palm T; Hua J; Youngster S; Hwang L; Liu HC; Li X; Peng P; Zhang Y; Zhao H; Zhang Z; Longley C; Mehlig M; Borowski V; Sai P; Viswanathan M; Jang E; Petti G; Liu S; Yang K; Filpula D
Bioconjug Chem; 2006; 17(6):1447-59. PubMed ID: 17105223
[TBL] [Abstract][Full Text] [Related]
9. Streptococcus pyogenes upregulates arginine catabolism to exert its pathogenesis on the skin surface.
Hirose Y; Yamaguchi M; Sumitomo T; Nakata M; Hanada T; Okuzaki D; Motooka D; Mori Y; Kawasaki H; Coady A; Uchiyama S; Hiraoka M; Zurich RH; Amagai M; Nizet V; Kawabata S
Cell Rep; 2021 Mar; 34(13):108924. PubMed ID: 33789094
[TBL] [Abstract][Full Text] [Related]
10. Intracellular expression of arginine deiminase activates the mitochondrial apoptosis pathway by inhibiting cytosolic ferritin and inducing chromatin autophagy.
Feng Q; Bian X; Liu X; Wang Y; Zhou H; Ma X; Quan C; Yao Y; Zheng Z
BMC Cancer; 2020 Jul; 20(1):665. PubMed ID: 32677906
[TBL] [Abstract][Full Text] [Related]
11. The Arginine Deiminase Pathway Impacts Antibiotic Tolerance during Biofilm-Mediated Streptococcus pyogenes Infections.
Freiberg JA; Le Breton Y; Harro JM; Allison DL; McIver KS; Shirtliff ME
mBio; 2020 Jul; 11(4):. PubMed ID: 32636245
[TBL] [Abstract][Full Text] [Related]
12. Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells.
Riess C; Del Moral K; Fiebig A; Kaps P; Linke C; Hinz B; Rupprecht A; Frank M; Fiedler T; Koczan D; Troschke-Meurer S; Lode HN; Engel N; Freitag T; Classen CF; Maletzki C
Cell Death Dis; 2022 Jun; 13(6):555. PubMed ID: 35717443
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma.
Syed N; Langer J; Janczar K; Singh P; Lo Nigro C; Lattanzio L; Coley HM; Hatzimichael E; Bomalaski J; Szlosarek P; Awad M; O'Neil K; Roncaroli F; Crook T
Cell Death Dis; 2013 Jan; 4(1):e458. PubMed ID: 23328665
[TBL] [Abstract][Full Text] [Related]
14. The role of arginine and the modified arginine deiminase enzyme ADI-PEG 20 in cancer therapy with special emphasis on Phase I/II clinical trials.
Synakiewicz A; Stachowicz-Stencel T; Adamkiewicz-Drozynska E
Expert Opin Investig Drugs; 2014 Nov; 23(11):1517-29. PubMed ID: 24965808
[TBL] [Abstract][Full Text] [Related]
15. Selective Intracellular Delivery of Recombinant Arginine Deiminase (ADI) Using pH-Sensitive Cell Penetrating Peptides To Overcome ADI Resistance in Hypoxic Breast Cancer Cells.
Yeh TH; Chen YR; Chen SY; Shen WC; Ann DK; Zaro JL; Shen LJ
Mol Pharm; 2016 Jan; 13(1):262-71. PubMed ID: 26642391
[TBL] [Abstract][Full Text] [Related]
16. Kinetic characterization of arginine deiminase and carbamate kinase from Streptococcus pyogenes M49.
Hering S; Sieg A; Kreikemeyer B; Fiedler T
Protein Expr Purif; 2013 Sep; 91(1):61-8. PubMed ID: 23867361
[TBL] [Abstract][Full Text] [Related]
17. Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells.
Khoury O; Ghazale N; Stone E; El-Sibai M; Frankel AE; Abi-Habib RJ
J Neurooncol; 2015 Mar; 122(1):75-85. PubMed ID: 25567351
[TBL] [Abstract][Full Text] [Related]
18. Purification, immobilization, and biochemical characterization of l-arginine deiminase from thermophilic Aspergillus fumigatus KJ434941: anticancer activity in vitro.
El-Sayed AS; Hassan MN; Nada HM
Biotechnol Prog; 2015; 31(2):396-405. PubMed ID: 25582958
[TBL] [Abstract][Full Text] [Related]
19. Rapid evolution of arginine deiminase for improved anti-tumor activity.
Ni Y; Liu Y; Schwaneberg U; Zhu L; Li N; Li L; Sun Z
Appl Microbiol Biotechnol; 2011 Apr; 90(1):193-201. PubMed ID: 21221572
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic profiling identifies distinct phenotypes for ASS1 positive and negative GBM.
Mörén L; Perryman R; Crook T; Langer JK; Oneill K; Syed N; Antti H
BMC Cancer; 2018 Feb; 18(1):167. PubMed ID: 29422017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
